Last week's bio-news
Kry closes $312M Series D after use of its telehealth tools grows 100% yoy
Kry allows you to consult a qualified health professional within minutes, via your smartphone or tablet. Through digital technology, Kry provides equitable access to high-quality health care – at the patient’s own convenience.
To date, Kry has helped over half a million patients, in the Nordics alone, to be at their best. Headquartered in Stockholm, Sweden, Kry operates in a number of European countries, and with further international expansion on the agenda. The companies employees are committed to improving the world's health through innovation – one patient at a time.
Kry closes $312M Series D after use of its telehealth tools grows 100% yoy | TechCrunch
Swedish digital health startup Kry, which offers a telehealth service (and software tools) to connect clinicians with patients for remote consultations, last raised just before the pandemic hit in Western Europe, netting a €140M Series C in January 2020. Today it’s announcing an oversubscribed sequel: The Series D raise clocks in at $312M (€262M) and […]
Proximie Raises $38M in Series B Funding
Proximie, a London, UK-based health technology platform company focused on digitising operating and diagnostic rooms, closed a $38m Series B equity financing.
The round was led by F-Prime Capital, with participation from new investors Questa Capital, Eight Roads, Maverick Ventures, and existing investors Global Ventures, BECO Capital and Cedar Mundi Ventures.
The company intends to use the funds to expand in the U.S. and European markets growing its commercial efforts, making new technology implementations, and conduct research and development activities.
Founded by Dr. Nadine Hachach-Haram FRCS (Plastics) – (B.E.M., British Empire Medal), in 2016, Proximie provides a platform that combines human expertise with augmented reality (AR), machine learning (ML), artificial intelligence (AI) and advanced telecommunications to build a network of operating rooms, where every interaction is captured, digitised, catalogued, and analysed.
Proximie Raises $38M in Series B Funding - FinSMEs
Proximie, a London, UK-based health technology platform company focused on digitising operating and diagnostic rooms, closed a $38m Series B equity financing
Rinri Therapeutics Raises £10M in Funding
Rinri Therapeutics, a Sheffield, England, UK-based biotechnology company developing a novel stem cell therapy to restore hearing, raised a total of £10m in funding.
Backers included existing investors Boehringer Ingelheim Venture Fund (BIVF), UCB Ventures and BioCity alongside the UK Government Future Fund.
The proceeds will support the development of the company’s novel stem cell therapy to reverse sensorineural hearing loss (SNHL).
Led by Dr Simon Chandler, CEO, Rinri Therapeutics is a private biotechnology company developing advanced stem cell-based therapeutics to restore hearing. The company’s technology seeks to reverse sensorineural hearing loss (SNHL) through the repair of the damaged cytoarchitecture in the inner ear. There are currently no pharmacological treatment options for SNHL patients.
Rinri Therapeutics Raises £10M in Funding - FinSMEs
Rinri Therapeutics, a Sheffield, England, UK-based biotechnology company developing a novel stem cell therapy to restore hearing, raised a total of £10m in funding
Cquestr8 Raises $300K in Seed Funding
Cquestr8, a London, UK-based carbon sequestration solution provider, raised $800k in funding.
The round was led by Counteract.
The company intends to use the funds for proof of concept development, ahead of customer engagement in 2022.
Co-founded by Steve Willis and Jerry Joynson in 2020, Cquestr8 is a non-profit research group seeking billion-tonne-scale carbon dioxide removal (CDR) technologies. The first commercial project to graduate from Herculean Climate Solutions, the company has developed carbon sequestration solutions, leveraging natural processes to safely lock away CO2 as stable ocean bicarbonate.
Cquestr8 Raises $300K in Seed Funding - FinSMEs
Cquestr8, a London, UK-based carbon sequestration solution provider, raised $800k in funding
Misfits Market Raises $200M in Series C Funding
Misfits Market, a Delanco, N.J.-based online grocer that offers quality, sustainably sourced food at a value, raised $200M in Series C funding.
The round was co-led by Accel and D1 Capital, with participation from existing investors Valor Equity Partners, Greenoaks Capital, Sound Ventures, and Third Kind Ventures. In conjunction with the funding, Accel’s Ryan Sweeney will join Misfits Market’s Board of Directors.
The company intends to use the funds to expand into every major grocery category and distribute across every underserved area nationwide.
Misfits Market Raises $200M in Series C Funding - FinSMEs
Misfits Market, a Delanco, N.J.-based online grocer that offers quality, sustainably sourced food at a value, raised $200M in Series C funding
Seed Health Raises $40M in Series A Funding
Seed Health, a Los Angeles, CA-based microbial sciences company developing next-generation probiotic applications and live biotherapeutics, raised $40M in Series A funding.
The round was led by The Craftory, alongside Artis Ventures, GISEV with participation from existing investors, Founders Fund and 8VC.
The funding will support:
rapid growth, power upcoming category launches, clinical research, etc., digital health initiatives, microbial stabilization technologies, and international expansion. Seed Health is a microbial sciences company pioneering applications of microbes for human and planetary health. In collaboration with academic partners, they accelerate breakthrough science into live biotherapeutics and innovations for consumer health.
Seed Health Raises $40M in Series A Funding - FinSMEs
Seed Health, a Los Angeles, CA-based microbial sciences company developing next-generation probiotic applications and live biotherapeutics, raised $40M in Series A funding
Glytec, a Waltham, MA-based provider of insulin management software across the continuum of care, raised $21m in financing.
The financing included:
$9m debt financing from SVB, and $12m equity investment led by Savitr Capital and other private investors. The company intends to use the funds to invest in research and development around patient safety, provider workflows and analytics, add talent to its workforce and enhance integrations with EHRs, mobile apps and other diabetes technology across the continuum of care.
Led by Ed Furlong, President and Chief Executive Officer, Glytec is an insulin management software company that delivers personalized diabetes treatment recommendations across the continuum of care, from hospital to home. eGMS helps providers track blood glucose data, detect and alert patients in glycemic disarray, provide personalized insulin dosing regimens, and get patients into target blood glucose range quickly.
Glytec Raises $21M in Funding - FinSMEs
Glytec, a Waltham, MA-based provider of insulin management software across the continuum of care, raised $21m in financing
pulseData Raises $16.5M in Series A Funding
pulseData, a New York City-based healthcare data science company focused on predictive algorithms for Chronic Kidney Disease and other chronic diseases, raised $16.5m in Series A funding.
The round was led by Bain Capital Private Equity and Two Bear Capital, with participation from Alumni Ventures Group and existing investors.
The company intends to use the funds to expand operations and its business reach.
Led by Hai Po Sun, Co-Founder and CTO, and Teddy Cha, Co-Founder and CEO, pulseData is building a suite of artificial intelligence solutions which predict the progression of chronic kidney disease and cardiorenal comorbidities.
pulseData Raises $16.5M in Series A Funding - FinSMEs
pulseData, a New York City-based healthcare data science company focused on predictive algorithms for Chronic Kidney Disease and other chronic diseases, raised $16.5m in Series A funding
Ophelia Raises $15m in Series A Funding
Ophelia, a NYC-based healthcare tech startup providing treatment for Opioid Use Disorder (OUD), raised $15m in Series A funding.
The round was led by Menlo Ventures with participation from Y Combinator, General Catalyst, Refactor Capital, and the founders of Flatiron Health, Warby Parker, Harry’s, Allbirds, PillPack, Carbon Health, and Lambda School.
The company intends to use the funds to continue to build and expand its services to patients across the U.S., to soon accept insurance, including Medicare and Medicaid.
Led by Zack Gray, Co-founder and CEO, Ophelia offers an alternative to traditional rehab for the treatment of OUD. Through its telemedicine platform, the company provides Medication-Assisted Treatment (MAT) in a private way for patients who otherwise have no way to access care. MAT works through a combination of medication to stop opioid withdrawal and cravings, plus support and therapy for patients when helpful.
Ophelia Raises $15m in Series A Funding - FinSMEs
Ophelia, a NYC-based healthcare tech startup providing treatment for Opioid Use Disorder (OUD), raised $15m in Series A funding
Edifice Health Raises $12M in Funding
Edifice Health, a San Mateo, CA-based immunological health and personalized nutrition company, raised $12m in funding.
The round was led by Leaps by Bayer with participation from Paladin Capital Group, Vertical Venture Partners, Ahren Innovation Capital, Ataraxia Capital Partners, Shanda Grab Ventures, Alafi Capital, and Taisho Pharmaceutical. Seed stage investors include Human Longevity and Performance Impact Venture Fund, Longevity Incubator Fund, Summer Venture Capital, Carlyle Global Advisors, M4 Capital GmbH, and Better Food Ventures.
Leaps by Bayer’s Naveen Krishnan, MD, MPhil, and Paladin Group’s Paul Conley, PhD, will join Edifice’s Board of Directors, alongside Santosh Padki, a San Francisco-based consumer products veteran, and David Furman, PhD, Edifice Founder, Leader of the Stanford Project, and Associate Professor of Applied Artificial Intelligence in Systems and Computational Immunology of Aging at the Buck Institute for Research on Aging.
The company intends to use the funds to grow its foundation of immunological science and add additional talent.
Edifice Health Raises $12M in Funding - FinSMEs
Edifice Health, a San Mateo, CA-based immunological health and personalized nutrition company, raised $12m in funding
Brave Care Raises $10M in Series A Funding
Brave Care, a Portland, Oregon-based modern pediatric healthcare company, raised $10M in Series A funding.
The round was led by City Light Capital, with participation from AV8, Interplay, Founders Co-op, Refactor, Learn Capital and other value-aligned investors like Gaingels.
The company intends to use the funds to open more clinics in new states, and enhance its complete care technology.
Led by founders Dr. Corey Fish, Darius Monsef, Maryam Taheri and Asa Miller, Brave Care gives parents access to care for children through its comprehensive model, including: remote care available 24/7 through its Parent App, primary and urgent care clinics open from 10am-10pm 365 days a year, and on-site pharmacies.
Brave Care Raises $10M in Series A Funding
Brave Care, a Portland, Oregon-based modern pediatric healthcare company, raised $10M in Series A funding
RNAimmune Raises $10M in Seed Financing
RNAimmune, Inc., a Gaithersburg, MD-based biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, raised $10m in seed funding.
Smooth River and Hong Kong Hongrun led the investment, with participation from Shanghai Walga Biotechnology, High Forest Investment and Terra Magnum Sigma. RNAimmune is a spin-off entity from Sirnaomics, a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases, who increased its investment in the company.
The company intends to use the funds to accelerate its research and development into mRNA vaccine and drug discovery focused on infectious disease, cancer, and rare diseases.
RNAimmune Raises $10M in Seed Financing
RNAimmune, Inc., a Gaithersburg, MD-based biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, raised $10m in seed funding
Halodoc Raises US$80M in Series C Financing
Halodoc, an Indonesian healthtech platform, raised US$ 80 million Series C financing.
The round was led by PT Astra Digital Internasional, a subsidiary of PT Astra International Tbk, with participation from Temasek, Telkomsel’s TMI, Acrew Diversify Capital Fund, Bangkok Bank, UOB Venture Management, Singtel Innov8, BliBli, Allianz X, Novo Holdings, and Openspace Ventures.
The funds will be used to deepen the company’s penetration in key healthcare verticals across Indonesia.
Founded in 2016 and led by Jonathan Sudartha, CEO, Halodoc is a digital healthcare platform that includes a mobile app and website allowing customers across Indonesia to have live consultations with more than 20,000 licensed doctors in the country at any time regardless of where they are. In 2020, the company launched an appointment service that connects over 2000 providers (hospitals, clinics, laboratories) to patients in over 180 cities across the country.
Halodoc Raises US$80M in Series C Financing - FinSMEs
Halodoc, an Indonesian healthtech platform, raised US$ 80 million Series C financing
Kenyan e-health startup TIBU Health raises seed funding round to help it scale
Kenyan e-health startup TIBU Health, a digital platform that decentralises primary outpatient care to bring it directly to patients, has raised a seed funding round to help it scale its operations.
Conceived in 2016, built in 2019, and launched to the public in early 2020, TIBU is an on-demand platform that connects people to healthcare workers in real-time, who deploy to a location and time of the patient’s choosing.
The startup has served over 10,000 patients since its launch, rolled out a comprehensive home-based vaccination service alongside Amref Health Africa, launched health packages focused on chronic diseases, and secured a variety of key partnerships, and it has now taken on a seed funding round to help it grow further.
https://disrupt-africa.com/2021/04/26/kenyan-e-health-startup-tibu-raises-seed-funding-round-to-help-it-scale/